Concepedia

Andrey Loboda

AL

Statistics

Publications

87

Citations

19.7K

H-Index

48

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Helsinki

Institute for Molecular Medicine Finland

Massachusetts General Hospital

Andrey Loboda is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, oncology, and molecular oncology.

Publications per year

2003–2025

87

Publications

87

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.9K citations · Full text

Medicine, Immunology, Oncology +17

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Céline Bellenguez, Fahri Küçükali, Iris E. Jansen et al. · Nature Genetics · 2022 · 2.5K citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations

Medicine, Immunology, Oncology +17

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Seung Tae Kim, Răzvan Cristescu, Adam J. Bass et al. · Nature Medicine · 2018 · 1.7K citations

Medicine, Cancer Biology, Oncology +17

Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors

Vinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel et al. · Cancer Cell · 2017 · 647 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 87